# Ultralow Dose PET Imaging of 18F-flurpiridaz

> **NCT07284576** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Akiva Mintz** · enrollment: 200 (estimated)

## Conditions studied

- Healthy Volunteer
- Coronary Arterial Disease
- Myocardial Ischemia
- Myocardial Infarction

## Interventions

- **DRUG:** 18F-flurpiridaz

## Key facts

- **NCT ID:** NCT07284576
- **Lead sponsor:** Akiva Mintz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-12-16
- **Primary completion:** 2030-06-30
- **Final completion:** 2030-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07284576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07284576, "Ultralow Dose PET Imaging of 18F-flurpiridaz". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07284576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*